| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919585 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
A low LNR is associated with extended survival in LN positive OCSCC. The survival benefit associated with PORT in this disease appears to be limited to those with a LNRÂ >Â 12.5%. Validation is required prior to the clinical implementation of our findings.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Damien Urban, Iris Gluck, M. Raphael Pfeffer, Zvi Symon, Yaacov R. Lawrence,